Interactive Spaced Education to Optimize Diabetes Care

Sponsor
Boston VA Research Institute, Inc. (Other)
Overall Status
Completed
CT.gov ID
NCT02082704
Collaborator
Agency for Healthcare Research and Quality (AHRQ) (U.S. Fed)
456
1
2
29
15.7

Study Details

Study Description

Brief Summary

Investigators are conducting a randomized controlled trial to determine whether an online team-based spaced education (SE) game can improve HbA1c levels among these patients with diabetes (primary aim). Secondary aims include determining the impact of the game on patients' pill possession ratio (PPR) of oral DM meds and their microalbumin/creatinine (M/C) ratio, ACE PPR, and ARB PPR.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: SE Game on DSME
  • Behavioral: SE Game on American History
N/A

Detailed Description

Participants will be randomized to one of two cohorts: (1) the intervention cohort will participate in an online team-based game on diabetes self-management education (DSME) and will receive a paper documents on American history, and (2) the 'attention control' cohort will participate in an online team-based game on American history and will receive a paper documents on DSME. Each game would consist of 2 questions per week x 25 weeks = 50 questions total per arm. The questions are delivered via email by the Qstream platform to the participants. Upon clicking on a hyperlink in the email, participants select an answer that is downloaded to a server. They are then provided with the answer to and explanation of the question, along with additional educational materials. Using an adaptive methodology, the spacing and content of the game material will be individualized for each clinician based on their performance. Home-based testing of HbA1c and M/C ratio will be conducted by patients at enrollment, 6 months and 12 months. If successful, this SE game will improve diabetes management among VA patients and improve patient outcomes. Given the growing use of email and the Internet by patients, SE games could be easily expanded to a broad audience of VA patients with varying health problems across the country. With content tailored to meet specific needs, SE games can be utilized as tools to improve patients' clinical outcomes by bolstering their health management behaviors.

Study Design

Study Type:
Interventional
Actual Enrollment :
456 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Interactive Spaced Education to Optimize Diabetes Care
Actual Study Start Date :
Jun 1, 2014
Actual Primary Completion Date :
Aug 1, 2015
Actual Study Completion Date :
Nov 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: SE Game on DSME

The intervention cohort will participate in an online team-based game on diabetes self-management education (DSME) and will receive a paper documents on American history,

Behavioral: SE Game on DSME
Investigators created an online educational game by incorporating game mechanics into an evidence-based form of online education, termed 'spaced education' (SE). Based upon two psychology research findings (the spacing and testing effects), SE has been shown in randomized trials to improves knowledge acquisition, boosts learning retention for up to two years, and durably improves clinical behavior.

Active Comparator: SE Game on American History

The 'attention control' cohort will participate in an online team-based game on American history and will receive a paper documents on DSME.

Behavioral: SE Game on American History
Investigators created an online educational game by incorporating game mechanics into an evidence-based form of online education, termed 'spaced education' (SE). Based upon two psychology research findings (the spacing and testing effects), SE has been shown in randomized trials to improves knowledge acquisition, boosts learning retention for up to two years, and durably improves clinical behavior.

Outcome Measures

Primary Outcome Measures

  1. HbA1c levels [Months 1-12]

Secondary Outcome Measures

  1. Microalbumenuria levels [microalbumin-creatinine ratio]. [Months 1-12]

  2. Pill possession ratios of oral diabetes medications. [Months 1-12]

  3. Treatment with angiotensin receptor blockers (ARB drugs) and angiotensin converting enzyme inhibitors (ACE inhibitors). [Months 1-12]

  4. Pill possession ratios of angiotensin receptor blockers (ARB drugs) and angiotensin converting enzyme inhibitors (ACE inhibitors). [Months 1-12]

  5. Weight / BMI [Months 1-12]

  6. Low-density lipoprotein (LDL), high-density lipoprotein (HDL), total cholesterol & triglyceride levels, [Months 1-12]

  7. Systolic and diastolic blood pressure. [Months 1-12]

  8. Clinic visit frequency. [Months 1-12]

  9. Initiation or alteration of insulin therapy [Months 1-12]

  10. Changes in oral diabetes medication regimen. [Months 1-12]

  11. Patient-perceived empowerment to manage their diabetes. [Months 1-12]

    Questionnaire

  12. Baseline knowledge levels of patients assessed via their initial responses to SE game questions -- DSME SE game cohort only. [Months 1-6]

  13. Analysis of SE game performance differences by patient-related variables (age, gender, geographic location, baseline HbA1c, etc.) -- DSME SE game cohort only. [Months 1-6]

  14. Patient-perceived acceptability of SE game interventions. [Months 1-6]

    Questionnaire

  15. Patient-perceived barriers and facilitators to the SE game intervention. [Months 1-6]

    Questionnaire

  16. Patient's perceptions of the optimal parameters for the SE game intervention. [Months 1-6]

    Questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients in the northeastern Veterans Affairs hospital system who are taking oral diabetes medications, have a PPR<80%, and have a HbA1c >7.5.
Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 Veterans Affairs Boston Healthcare System Boston Massachusetts United States 02130

Sponsors and Collaborators

  • Boston VA Research Institute, Inc.
  • Agency for Healthcare Research and Quality (AHRQ)

Investigators

  • Principal Investigator: B. Price Kerfoot, MD EdM, VA Boston Healthcare System
  • Principal Investigator: Paul R. Conlin, MD, VA Boston Healthcare System

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Boston VA Research Institute, Inc.
ClinicalTrials.gov Identifier:
NCT02082704
Other Study ID Numbers:
  • AHRQ 1R01HS019708-01A1
First Posted:
Mar 10, 2014
Last Update Posted:
Jul 12, 2017
Last Verified:
Jul 1, 2017
Keywords provided by Boston VA Research Institute, Inc.
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 12, 2017